TMED News 0.1000 Trimedyne Inc (TMED)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Trimedyne Inc (TMED) 0.1000 $TMED

Trimedyne Reports Its Financial Results for the Quarter Ended December 31, 2013
Marketwire - Wed Feb 19, 8:15AM CST
TRIMEDYNE, INC. (OTCQB: TMED) (OTCBB: TMED) today reported its financial results for the first quarter of its fiscal year.

Trimedyne Reports Financial Results for the Quarter and Fiscal Year Ended September 30, 2013
Marketwire - Wed Jan 15, 7:01AM CST
TRIMEDYNE, INC. (OTCBB: TMED) (OTCQB: TMED) reported revenues of $5,989,000 for the fiscal year ended September 30, 2012, a 1.5% decrease from revenues of $6,080,000 for the prior fiscal year. The decrease was primarily due to the decrease in domestic Laser sales combined with the delaying of shipments of Fibers, Needles and Switch Tips resulting from the relocation to our new manufacturing facility in Irvine, California.

Global Medical Laser Systems Market Report 2013-2018: Global Aesthetics Laser Market Poised to Grow
M2 - Thu Sep 05, 9:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/np483b/medical_laser#summary) has announced the addition of the "Medical Laser Systems - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Medical Laser Systems in US$ Million by the following Product Segments: - Surgical Lasers - Aesthetic Lasers - Ophthalmic Lasers - Diagnostic Lasers - Therapeutic Lasers - Accessories & Services. The report profiles 139 companies including many key and niche players such as: - AngioDynamics Inc. - Bausch & Lomb Incorporated - BIOLASE Inc. - Biolitec AG - Cardiogenesis Corporation - Carl Zeiss Meditec AG - Coherent Inc. - Cutera Inc - Cynosure Inc. - Palomar Medical Technologies Inc. - Dornier Medtech GmbH - Ellex Medical Lasers Limited - IRIDEX Corporation - Lumenis Ltd - Lynton Lasers Ltd - Nidek Co Ltd. - Novartis AG - PhotoMedex Inc. - Radiancy Inc. - Spectranetics Corporation - Syneron Medical Ltd. - Candela Corporation - Topcon Corporation - Trimedyne Inc. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends And Issues 3. Medical Laser Systems: Product Overview 4. Product Introductions/Approvals 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 139 (including Divisions/Subsidiaries - 175) - The United States (87) - Canada (3) - Japan (6) - Europe (64) - - France (6) - - Germany (28) - - The United Kingdom (6) - - Italy (8) - - Spain (1) - - Rest of Europe (15) - Asia-Pacific (Excluding Japan) (12) - Middle East (3) For more information visit http://www.researchandmarkets.com/research/np...er#summary

Trimedyne Reports Its Financial Results for the Quarter and Nine Months Ended June 30, 2013
ACCESSWIRE - Thu Aug 22, 8:07AM CDT
Irvine, CA, August 22, 2013 - (Accesswire) - TRIMEDYNE, INC. (OTCQB: TMED) today reported its financial results for the quarter and nine months ended June 30, 2013.

Trimedyne Reports Its Financial Results for the Quarter and Six Months Ended March 31, 2013
Marketwire - Thu Jun 20, 8:01AM CDT
TRIMEDYNE, INC. (OTCQB: TMED) today reported its financial results for the quarter and six month period ended March 31, 2013.

Trimedyne Reports Financial Results For The Quarter And Fiscal Year Ended September 30, 2012
PR Newswire - Fri Feb 01, 8:00AM CST
TRIMEDYNE, INC. (OTCBB "TMED" reported revenues of $6,080,000 for the fiscal year ended September 30, 2012, a 9% decrease from revenues of $6,656,000 for the prior fiscal year. The decrease in revenues was largely due to a decrease in sales of Lasers, partially offset by an increase in sales of Fibers, Needles and Tips.

John C. Chiu, M.D., Has Agreed to Be Medical Director and Chief Investigator of the Clinical Trials of Hyperdyne, Inc., a Subsidiary Being Created by Trimedyne
Marketwire - Mon Jan 07, 8:00AM CST
TRIMEDYNE, INC. ("Trimedyne" (OTCBB: TMED), today announced that John C. Chiu, M.D., an internationally respected neurosurgeon who practices in Newbury Park, CA, has agreed to serve as Medical Director and Chief Investigator of the three (3) randomized, controlled clinical trials to be conducted, subject to receiving funding, by Orthodyne, Inc., ("Orthodyne" , a subsidiary being a organized by Trimedyne.

Professor Anthony J. Costello, M.D. Agrees to Conduct Pre-Clinical Testing and Lead the Clinical Trials in Asia and Southeast Asia of Urodyne, Inc. and Hyperdyne, Inc., Subsidiaries Being Created by Trimedyne
Marketwire - Thu Dec 27, 8:00AM CST
TRIMEDYNE, INC. ("Trimedyne" (OTCBB: TMED) today announced Professor Anthony J. Costello, M.D., Head of the Department of Urology of the Royal Melbourne Hospital of the University of Melbourne (Australia), will serve as Lead Investigator in Asia and Southeast Asia, subject to their receiving funding, of the three (3), 300 patient, randomized, controlled clinical trials of Urodyne, Inc. ("Urodyne" in the treatment of Benign Prostatic Hyperplasia or BPH (commonly called an enlarged prostate) and the treatment of Urinary Incontinence and Fecal Incontinence and, subject to their receiving funding, the two (2), 300 patient randomized, controlled clinical trials of Hyperdyne, Inc. ("Hyperdyne" in the treatment of Uncontrolled Hypertension (high blood pressure not controllable by drugs) in Endoscopic and Percutaneous (balloon angioplasty-like) Procedures. He will select the medical centers to participate in the clinical trials in these areas of the world and train the physicians of the medical centers in the co

Graham M. Watson, M.D., Agrees to Serve as Lead Investigator of the Clinical Trials in Europe and Middle East of Urodyne, Inc. and Hyperdyne, Inc., Subsidiaries Trimedyne Plans to Create
Marketwire - Fri Dec 21, 8:00AM CST
TRIMEDYNE, INC. ("Trimedyne" (OTCBB: TMED), today announced Graham M. Watson, M.D., has agreed to serve as Lead Investigator in Europe and the Middle East, subject to receiving funding, of the three (3), 300 patient, randomized clinical trials of Urodyne, Inc. ("Urodyne" to treat Benign Prostatic Hyperplasia or BPH, commonly referred to as an "Enlarged Prostate," urinary incontinence and fecal incontinence in Endoscopic Procedures and, subject to receiving funding, the two (2) 300 patient randomized, controlled clinical trials of Hyperdyne, Inc. ("Hyperdyne" to treat Hypertension not controllable by drugs, one in Endoscopic Procedures and the other in Percutaneous (angioplasty-like) Procedures.

Robert S. Cowles, III, M.D. Joins Urodyne, Inc. and Hyperdyne, Inc., Two Subsidiaries Trimedyne Plans to Organize, as Co-Chairman and Medical Director
Marketwire - Thu Dec 20, 8:01AM CST
TRIMEDYNE, INC. ("Trimedyne" (OTCBB: TMED) today announced that Robert S. Cowles, III, M.D. has agreed to serve as Co-Chairman with Dr. Marvin P. Loeb of the Boards of Directors and as Medical Director of Urodyne, Inc. ("Urodyne" and Hyperdyne, Inc. ("Hyperdyne" , two subsidiaries Trimedyne plans to organize. (See Trimedyne's Press Release of November 28, 2012).

Robert S. Cowles, III, M.D. Joins Trimedyne as Its Medical Director
Marketwire - Wed Dec 19, 8:01AM CST
TRIMEDYNE, INC. (OTCBB: TMED), today announced that Robert S. Cowles, III, M.D. has agreed to serve as Medical Director of Trimedyne. He will review Trimedyne's new technologies and advise Trimedyne on the design of the clinical trials to be conducted, subject to receipt of funding, by the seven (7) subsidiaries Trimedyne plans to organize (See Trimedyne's Press Release dated November 28, 2012).
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UnitedHealth’s CMS Audit Shock Puts Disclosures Under Lens

Updated Category News Views 123

Medicare Advantage's audit bill just landed with a nasty thud. UnitedHealth Group shares fell more than 10% on November 18 after the Centers for Medicare & Medicaid Services proposed new anti-fraud, audit, and repayment rules for the program. For holders of NYSE:UNH, this was not some sleepy policy memo buried in a federal filing cabinet. It was a hard reminder that...

Continue Reading
Cedars-Sinai and nference Build a Living Data Engine

Updated Category News Views 65

Five million patient histories are not a flashy product demo. They are a serious raw-material advantage, provided the data can be protected, organized, and made useful without turning clinical research into a carnival of loose claims. That is the real weight behind nference's long-term collaboration with Cedars-Sinai, announced November 20, 2026. The pair plan to build a...

Continue Reading
YYForce Security Win Adds Recurring Singapore Revenue Base

Updated Category News Views 81

A retail-property security mandate rarely makes anyone pound the table, and frankly it should not. Still, YYForce has landed a tangible two-year contract in Singapore worth roughly S$831,120, with subsidiary Uniforce Security Services set to begin work on December 1, 2026. For NASDAQ:YFOR investors, this is the kind of small, operationally real win that deserves a sober...

Continue Reading
PinnacleQM Makes Its Enterprise Case More Visible

Updated Category News Views 118

Six pages were never going to carry the weight of a complicated enterprise pitch. PinnacleQM has rebuilt its public face from a basic brochure into a library of more than 50 pages, putting its quality engineering, testing, automation and AI assurance work in clearer view for Australian technology and business buyers. This is not the sort of announcement that changes a...

Continue Reading
Mindgruve's Tech Hire Puts Sightline Growth in Focus

Updated Category News Views 67

Agency technology hires usually land with all the thunder of a stapler dropping, but this one deserves a closer look. Mindgruve has named Steve Terjeson vice president of technology, handing a former WPP Choreograph executive the job of leading its software development and data engineering teams. The assignment is not vague: push AI innovation, make the proprietary...

Continue Reading
Saban Center Partnership Gives Health Learning a Lift

Updated Category News Views 118

A dinosaur race may sound like pure kid bait, but the underlying idea is sturdier than that. Cardiac Solutions and the Seale family are backing an interactive health-and-performance exhibit at Tuscaloosa’s planned Saban Center, a project intended to turn questions about movement, fitness, heart rate and oxygen levels into something children can actually touch, test and...

Continue Reading
Hydron’s Bailey Test Puts RNG Cost Claims to Real Work

Updated Category News Views 55

Landfill gas is messy stuff, which is exactly why Hydron Energy’s Bailey Landfill demonstration in Chilliwack deserves more attention than another clean-energy press release. The British Columbia company is putting its INTRUPTor™ gas-separation system into an operating environment alongside FortisBC and the City of Chilliwack, where the machinery has to deal with real...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 155

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
L’Oréal’s Women of Worth Shows Why Brand Patience Matters

Updated Category News Views 120

Twenty-one years is a long time to keep a corporate promise from turning into wallpaper. L’Oréal Paris gathered its 2026 Women of Worth class at the Ebell in Los Angeles on November 18, recognizing 10 nonprofit leaders working on problems that do not yield to a glitzy evening or a tidy slogan. That distinction matters. Cancer survivorship, trafficking prevention,...

Continue Reading
COFE+ Barista Test Puts Robotic Coffee on the Clock

Updated Category News Views 17

A swan latte taking 18 seconds less is not nothing, even if it is hardly a verdict on the future of coffee. COFE+, the seventh-generation robotic barista from Shanghai Hi-Dolphin Robot Technology, beat an award-winning human barista across five drinks at a live November 14 competition in Yiwu. That is a clean, visible demonstration of what machines are increasingly built...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Collaboration in Nuclear Electric Propulsion

Updated Category News Views 179

Exciting Advances in Nuclear Electric Propulsion Space Nuclear Power Corporation has embarked on a groundbreaking partnership with the United States Space Force (USSF) and the Space Strategic Technology Institute hosted by a prominent Michigan university. This collaboration aims to develop advanced nuclear electric propulsion systems designed for future space missions....

Continue Reading
Dali's Global Ecological Forum: A Step Towards Greener Futures

Updated Category News Views 81

Dali's Ecological Achievements Take Center Stage Dali, a picturesque city in Yunnan, China, has become a beacon of ecological progress, recently showcasing its achievements at the 2024 Erhai Forum on Global Ecological Civilization Construction. With a theme centered on 'Working Together to Promote Eco-Friendly Modernization', this important event took place in October and...

Continue Reading
Opportunity for Investors to Lead Wolfspeed Securities Case

Updated Category News Views 301

Update for Investors of Wolfspeed, Inc. Wolfspeed, Inc. (NYSE: WOLF) has become the center of attention as investors seek justice after experiencing significant losses. Those who have purchased securities between specific dates are being invited to take action regarding a potential case of securities fraud. Understanding the Class Action Opportunity The Rosen Law Firm, a...

Continue Reading
Updates from Schouw & Co.'s Share Buy-Back Programme Progress

Updated Category News Views 115

Overview of Schouw & Co. Share Buy-Back Programme On May 5, Schouw & Co. took a significant step in enhancing shareholder value by launching a share buy-back programme. As outlined in their company announcement from May 2, the initiative allows for the acquisition of shares valued up to DKK 120 million. The duration of this programme extends from May 5 to December 31....

Continue Reading
Academy Sports Expands Across Multiple States with New Stores

Updated Category News Views 213

Academy Sports and Outdoors Expands Its Reach Academy Sports and Outdoors, Inc. (NASDAQ: ASO) is executing an ambitious plan to bolster its presence through multi-state expansion. This entails the opening of new store locations while nurturing community partnerships aimed at enhancing value for shoppers. Recent Store Openings Recently, the retailer has launched new...

Continue Reading